Federal Register Notice: FDA is making available grant funds for supporting the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH). The goal of the ICH is to bring together leading global drug regulatory agencies and pharmaceutical manufacturer associations to achieve greater harmonization of technical standards to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner. The program’s grant funds will support the ICH to develop a series of international guidelines for implementation according to each region’s requirements aimed at achieving the following: (1) Develop and register safe, effective, and high quality medicines in the most efficient and cost effective manner; (2) prevent unnecessary duplication of clinical trials and minimize the use of animal testing without compromising safety and effectiveness, and (3) provide public assurance that the rights, safety, and well-being of subjects are protected during clinical trials. The ICH aims to make information readily available on ICH, ICH activities, and ICH guidelines to any country or company that requests the information. The application due date is 9/30. To view t his notice, click here.